Sciencepulse

RFK Jr. Opens Access to Six Unproven Peptides, Reportedly Overruling FDA

Policy·October 29, 2026

RFK Jr. Opens Access to Six Unproven Peptides, Reportedly Overruling FDA

Health and Human Services Secretary Robert F. Kennedy Jr. has moved six peptides that are popular with supporters of his Make America Healthy Again movement under what the department calls an "enforcement discretion policy." According to the report, the decision went ahead over the objections of the Food and Drug Administration, putting the secretary's judgment in place of the agency's own review.

Enforcement discretion is a tool regulators use to say they will not pursue action against a product, even though it has not gone through the normal approval process. It is not an approval. It does not mean the agency has found a product safe or effective, only that it has chosen not to act against it for now. Peptides are short chains of amino acids, and many of those sold in the wellness market have limited human testing behind them. Some have previously been flagged by the FDA as lacking adequate safety data.

Supporters are likely to frame the change as cutting red tape for people who want access to treatments the medical system has been slow to offer. Skeptics are likely to focus on the other side of the ledger: thin clinical evidence, questions about quality control in compounded products, and the precedent of a health secretary overriding career scientists on a drug-safety question.

The summary of the report does not name all six peptides, so the exact scope of the policy and any conditions attached to it should be checked against the official notice. Key things to watch include which products are covered, whether the FDA publicly responds, and whether compounding pharmacies and online sellers start marketing the peptides on the strength of the new policy.

Reporting based on an external source.